Cargando…

Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

BACKGROUND: The clinical relevance of pancreatic intraepithelial neoplasia (PanIN) at the resection margin of pancreatic ductal adenocarcinoma remains unknown. We aimed to investigate its clinical impact at the pancreatic transection margin (PTM) and, based on the result, determine the prognostic va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamiyan, Tsengelmaa, Shiraki, Takayuki, Kurata, Yoshihiro, Ichinose, Masanori, Kubota, Keiichi, Imai, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310330/ https://www.ncbi.nlm.nih.gov/pubmed/32571348 http://dx.doi.org/10.1186/s12957-020-01900-0

Ejemplares similares

Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
por: Kurata, Yoshihiro, et al.
Publicado: (2021)

Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma
por: Shiraki, Takayuki, et al.
Publicado: (2018)

Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2018)

Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion
por: Imai, Yasuo, et al.
Publicado: (2023)

The Impact of Venous Invasion on the Postoperative Recurrence of pT1–3N0cM0 Gastric Cancer
por: Imai, Yasuo, et al.
Publicado: (2023)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022)

Gastric Adenocarcinoma of the Fundic Gland Type: A Case Report
por: Kakumoto, Akinari, et al.
Publicado: (2021)

Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
por: Sahakyan, Mushegh A., et al.
Publicado: (2021)

Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma
por: Holm, Maia Blomhoff, et al.
Publicado: (2022)

Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
por: Park, Sejun, et al.
Publicado: (2023)

Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head
por: You, Yunghun, et al.
Publicado: (2019)

When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma
por: Iso, Yukihiro, et al.
Publicado: (2014)

KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence
por: Amintas, Samuel, et al.
Publicado: (2022)

The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis
por: Obonyo, Dennis, et al.
Publicado: (2023)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopy
por: Xu, Jian, et al.
Publicado: (2017)

Prospective Evaluation of Resection Margins Using Standardized Specimen Protocol Analysis among Patients with Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Garnier, Jonathan, et al.
Publicado: (2021)

Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes
por: Badowska-Kozakiewicz, Anna, et al.
Publicado: (2022)

Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?
por: Jung, Ji-Hye, et al.
Publicado: (2022)

ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma—Does Surgery Tell the Whole Story?
por: Sahakyan, Mushegh A., et al.
Publicado: (2021)

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
por: Westgaard, Arne, et al.
Publicado: (2008)

Irreversible electroporation in borderline resectable pancreatic adenocarcinoma for margin accentuation
por: Papoulas, Michail, et al.
Publicado: (2018)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features
por: PENG, JIE, et al.
Publicado: (2013)

The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma
por: Gao, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ef4cemd416pc2gtqu4pv62rb29